| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | General Counsel
1 company
Christine Ring is Chief Legal Officer at NRIX. From February 2021 to October 2026, the filings on record show 0 open-market purchases and 63 sales. Christine Ring's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $396K at current prices.
Our model assigns Christine Ring a strong insider score of 75/100, based on 59 past trades. Over a 12-month horizon, 86.0% of those trades were profitable, with an average 12-month return of +27.5%.
The NRIX filings lean toward selling, a net 304,318 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 1,760 | $7.99 | $14,062.75 | -9.2% | +56.1% | +145.9% | |
| Oct 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Legal Officer | Sale+OE | 1,232 | $5.20 | $6,403.20 | -7.5% | +49.7% | +330.6% | |
| Jul 31, 2023 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,420 | $9.65 | $13,709.67 | -10.2% | -45.8% | +113.9% | |
| May 1, 2023 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 682 | $9.88 | $6,735.64 | -6.4% | -1.9% | +21.4% | |
| Jan 30, 2023 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 848 | $11.78 | $9,989.10 | -10.5% | -16.6% | -32.7% | |
| Oct 31, 2022 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 699 | $12.88 | $9,003.47 | -10.2% | -6.8% | -56.1% | |
| Aug 1, 2022 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 712 | $15.67 | $11,157.04 | -13.4% | -17.4% | -38.4% | |
| May 2, 2022 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 660 | $11.75 | $7,755.00 | -16.2% | +28.8% | -21.4% | |
| Jan 10, 2022 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $27.14 | $32,568.00 | -48.3% | -46.8% | -52.9% | |
| Dec 10, 2021 | NRIX Nurix Therapeutics, Inc. | General Counsel | Sale+OE | 1,200 | $29.04 | $34,848.00 | -48.3% | -51.0% | -58.2% |